177 related articles for article (PubMed ID: 20426824)
1. Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis.
Ferlini A; Bovolenta M; Neri M; Gualandi F; Balboni A; Yuryev A; Salvi F; Gemmati D; Liboni A; Zamboni P
BMC Med Genet; 2010 Apr; 11():64. PubMed ID: 20426824
[TBL] [Abstract][Full Text] [Related]
2. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
3. Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients.
Weinstock-Guttman B; Zivadinov R; Cutter G; Tamaño-Blanco M; Marr K; Badgett D; Carl E; Elfadil M; Kennedy C; Benedict RH; Ramanathan M
PLoS One; 2011 Feb; 6(2):e16802. PubMed ID: 21340025
[TBL] [Abstract][Full Text] [Related]
4. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F
Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
7. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
8. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
[TBL] [Abstract][Full Text] [Related]
9. Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis.
Hackstein H; Bitsch A; Bohnert A; Hofmann H; Weber F; Ohly A; Linington C; Mäurer M; Poser S; Rieckmann P; Bein G
J Neuroimmunol; 2001 Feb; 113(2):240-8. PubMed ID: 11164908
[TBL] [Abstract][Full Text] [Related]
10. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Cree BA; Rioux JD; McCauley JL; Gourraud PA; Goyette P; McElroy J; De Jager P; Santaniello A; Vyse TJ; Gregersen PK; Mirel D; Hafler DA; Haines JL; Pericak-Vance MA; Compston A; Sawcer SJ; Oksenberg JR; Hauser SL; ;
PLoS One; 2010 Jun; 5(6):e11296. PubMed ID: 20593013
[TBL] [Abstract][Full Text] [Related]
11. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition.
Van der Walt A; Stankovich J; Bahlo M; Taylor BV; Van der Mei IA; Foote SJ; Rubio JP; Kilpatrick TJ; Butzkueven H
Mult Scler; 2011 Mar; 17(3):344-52. PubMed ID: 21149397
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.
Barcellos LF; Oksenberg JR; Begovich AB; Martin ER; Schmidt S; Vittinghoff E; Goodin DS; Pelletier D; Lincoln RR; Bucher P; Swerdlin A; Pericak-Vance MA; Haines JL; Hauser SL;
Am J Hum Genet; 2003 Mar; 72(3):710-6. PubMed ID: 12557126
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis.
de la Concha EG; Arroyo R; Crusius JB; Campillo JA; Martin C; Varela de Seijas E; Peña AS; Clavería LE; Fernandez-Arquero M
J Neuroimmunol; 1997 Dec; 80(1-2):172-8. PubMed ID: 9413274
[TBL] [Abstract][Full Text] [Related]
15. Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis.
Graves MC; Benton M; Lea RA; Boyle M; Tajouri L; Macartney-Coxson D; Scott RJ; Lechner-Scott J
Mult Scler; 2014 Jul; 20(8):1033-41. PubMed ID: 24336351
[TBL] [Abstract][Full Text] [Related]
16. HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients.
Bennetts BH; Teutsch SM; Buhler MM; Heard RN; Stewart GJ
Hum Immunol; 1999 Sep; 60(9):886-93. PubMed ID: 10527398
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course.
Bartolomei I; Salvi F; Galeotti R; Salviato E; Alcanterini M; Menegatti E; Mascalchi M; Zamboni P
Int Angiol; 2010 Apr; 29(2):183-8. PubMed ID: 20351674
[TBL] [Abstract][Full Text] [Related]
18. High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function.
Bestetti I; Castronovo C; Sironi A; Caslini C; Sala C; Rossetti R; Crippa M; Ferrari I; Pistocchi A; Toniolo D; Persani L; Marozzi A; Finelli P
Hum Reprod; 2019 Mar; 34(3):574-583. PubMed ID: 30689869
[TBL] [Abstract][Full Text] [Related]
19. Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population.
Marrosu MG; Cocco E; Costa G; Murru MR; Mancosu C; Murru R; Lai M; Sardu C; Contu P
J Neurol; 2006 Feb; 253(2):208-13. PubMed ID: 16096810
[TBL] [Abstract][Full Text] [Related]
20. An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene.
Ramagopalan SV; McMahon R; Dyment DA; Sadovnick AD; Ebers GC; Wittkowski KM
BMC Med Genet; 2009 Feb; 10():10. PubMed ID: 19193207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
